Falcons' Fortunes - FACIT's Annual Pitch Competition
Opportunity for Ontario Cancer Researchers to vie for the
"Ernsting Entrepreneurship Award"
Falcons' Fortunes (based on the popular TV series Dragons' Den) invites Ontario-based entrepreneurs working in the oncology space to pitch innovative research ideas to an external panel of judges. Hosted by the FACIT Falcons (i.e. the FACIT team), this annual event offers $50,000 in Prospects funding to invest in the most promising oncology research idea. While the research idea should be novel and sound, the competition is for the best pitch i.e. the presentation that best convinces the investor judging panel on the value of the idea and how $50,000 would improve and/or better illustrate the potential, and if possible commercial, value of the innovative idea itself.
The Falcons’ Fortunes event endeavors to enhance, support and celebrate a culture of commercialization in Ontario, such as the cultivation of skill sets that enable ideas to be successfully pitched to investors and promotion of entrepreneurial spirit.
The Falcons’ Fortunes pitch competition is open to any Ontario-based entrepreneurial researcher (e.g. academia, research institutions, research hospitals, startups, etc.) working in the oncology space. Joint pitches from up to two researchers are also eligible. Basically, anyone with the entrepreneurial itch should participate!
How to participate:
The next call to participate will be issued in 2019.
2017: Development of a Multi-mechanistic Vaccinia Virus-based Platform for the Treatment of Pancreatic Cancer
The novel platform delivers sustained and amplified viral-mediated cell killing specific to pancreatic cancer (PCa) via the production of PCa cell-targeted amiR-containing exosomes.
An economical port, bag and belt system for urostomy patients that aims to reduce their rate of complications, facilitate application, and reduce social stigma; overall helping improve the quality of life of bladder cancer patients.
A mobile health application that seeks to merge tracking of patients’ side effects and situations related to cancer treatments with patient-provider communication.
A new manufacturing process that creates microbubbles that are only responsive to the ultrasound frequency used in cancer treatment, enabling significantly lower volumes and costs while potentially improving safety.